US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist
  • 48.340
  • +0.360+0.75%
Trading Nov 22 10:08 ET
121.20BMarket Cap25.71P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
11.49%14.16B
6.53%11.38B
2.35%11.12B
2.32%46.44B
6.50%12.2B
-3.35%12.7B
-0.56%10.68B
8.06%10.86B
15.86%45.39B
10.00%11.46B
Operating revenue
12.32%13.44B
7.83%10.75B
2.37%10.46B
0.17%43.07B
1.81%10.92B
-4.15%11.96B
-1.49%9.97B
5.66%10.22B
13.87%43B
7.31%10.73B
Cost of revenue
6.35%4.09B
4.35%3.41B
11.69%3.44B
3.95%14.24B
8.41%4.05B
0.26%3.84B
0.55%3.27B
6.91%3.08B
11.75%13.7B
7.45%3.73B
Gross profit
13.72%10.07B
7.50%7.97B
-1.35%7.68B
1.62%32.21B
5.58%8.15B
-4.84%8.86B
-1.04%7.41B
8.52%7.78B
17.73%31.69B
11.27%7.72B
Operating expense
10.76%5.98B
8.32%5.69B
9.77%5.45B
10.11%21.82B
15.76%6.2B
15.92%5.4B
0.69%5.25B
8.32%4.96B
11.48%19.81B
4.61%5.36B
Selling and administrative expenses
3.96%2.68B
3.11%2.66B
-0.08%2.61B
1.91%10.69B
1.24%2.93B
-2.46%2.58B
0.04%2.58B
9.58%2.61B
9.81%10.49B
4.97%2.9B
Research and development costs
11.37%1.85B
4.54%1.7B
9.98%1.72B
0.33%6.73B
2.69%1.87B
-4.21%1.66B
-1.69%1.63B
4.97%1.56B
17.81%6.71B
15.02%1.82B
Depreciation amortization depletion
-14.77%479M
-8.61%499M
14.93%562M
5.80%2.17B
25.82%575M
-18.08%562M
18.44%546M
8.91%489M
29.94%2.05B
8.81%457M
-Depreciation and amortization
-14.77%479M
-8.61%499M
14.93%562M
5.80%2.17B
25.82%575M
-18.08%562M
18.44%546M
8.91%489M
29.94%2.05B
8.81%457M
Other operating expenses
62.37%971M
65.87%831M
84.87%562M
295.73%2.22B
356.11%821M
247.29%598M
-4.21%501M
14.72%304M
-40.59%562M
-49.44%180M
Operating profit
18.35%4.09B
5.50%2.28B
-20.91%2.23B
-12.53%10.39B
-17.45%1.95B
-25.65%3.46B
-5.01%2.16B
8.88%2.82B
29.89%11.88B
29.98%2.37B
Net non-operating interest income expense
24.57%-132M
-175.68%-204M
-1,357.14%-102M
-121.88%-639M
-363.41%-380M
-243.14%-175M
3.90%-74M
91.03%-7M
22.16%-288M
34.40%-82M
Non-operating interest income
-6.99%133M
-4.17%92M
-6.21%151M
215.61%546M
34.48%117M
175.00%143M
300.00%96M
1,510.00%161M
5,666.67%173M
422.22%87M
Non-operating interest expense
-16.67%265M
-8.78%135M
50.60%253M
42.95%659M
-117.16%-29M
208.74%318M
46.53%148M
90.91%168M
18.51%461M
48.25%169M
Total other finance cost
----
----
----
--526M
----
----
----
----
----
----
Other net income (expense)
-86.07%-454M
-123.86%-685M
-118.44%-782M
-122.03%-2.6B
-194.69%-1.7B
87.31%-244M
63.74%-306M
-84.54%-358M
-19.61%-1.17B
737.01%1.79B
Gain on sale of security
----
----
----
-253.70%-83M
----
----
----
----
28.57%54M
----
Special income (charges)
-86.07%-454M
-95.65%-765M
-160.37%-703M
-105.47%-2.52B
-192.86%-1.61B
87.31%-244M
53.67%-391M
-53.41%-270M
-19.98%-1.23B
630.89%1.74B
-Less：Restructuring and merger&acquisition
0.76%264M
112.89%677M
182.35%720M
20.93%1.58B
373.42%748M
-23.39%262M
-50.16%318M
49.12%255M
58.86%1.31B
-48.53%158M
-Less:Impairment of capital assets
4,400.00%180M
---354M
-213.33%-17M
297.36%896M
141.23%877M
-99.75%4M
--0
200.00%15M
-336.46%-454M
-14,280.00%-2.13B
-Less:Other special charges
145.45%10M
----
----
-89.73%38M
-105.58%-13M
-340.00%-22M
----
----
7,300.00%370M
--233M
Other non- operating income (expenses)
----
----
10.23%-79M
----
----
----
----
-388.89%-88M
----
----
Income before tax
15.38%3.5B
-21.89%1.39B
-45.15%1.35B
-31.37%7.15B
-102.97%-121M
13.58%3.04B
31.51%1.78B
5.91%2.46B
33.65%10.42B
187.99%4.08B
Income tax
30.91%737M
10.33%299M
-64.27%164M
-20.14%1.6B
-66.04%309M
-6.32%563M
66.26%271M
38.25%459M
28.75%2.01B
232.12%910M
Earnings from equity interest net of tax
20.00%78M
137.50%24M
-408.33%-37M
-269.12%-115M
-4,366.67%-128M
828.57%65M
-328.57%-64M
-60.00%12M
74.36%68M
-83.33%3M
Net income
12.06%2.84B
-22.81%1.12B
-42.96%1.15B
-35.93%5.44B
-117.61%-558M
22.08%2.54B
18.61%1.45B
-0.40%2.01B
35.12%8.48B
173.34%3.17B
Net income continuous Operations
12.06%2.84B
-22.81%1.12B
-42.96%1.15B
-35.93%5.44B
-117.61%-558M
22.08%2.54B
18.61%1.45B
-0.40%2.01B
35.12%8.48B
173.34%3.17B
Minority interest income
123.08%29M
-66.67%4M
-7.14%13M
-68.14%36M
-105.26%-3M
333.33%13M
-73.33%12M
75.00%14M
101.79%113M
470.00%57M
Net income attributable to the parent company
11.49%2.82B
-22.44%1.11B
-43.21%1.13B
-35.49%5.4B
-117.84%-555M
21.63%2.53B
22.13%1.44B
-0.70%2B
34.52%8.37B
170.76%3.11B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.49%2.82B
-22.44%1.11B
-43.21%1.13B
-35.49%5.4B
-117.84%-555M
21.63%2.53B
22.13%1.44B
-0.70%2B
34.52%8.37B
170.76%3.11B
Basic earnings per share
11.94%1.125
-21.93%0.445
-43.13%0.455
-35.58%2.155
-137.93%-0.22
21.08%1.005
21.28%0.57
-0.62%0.8
34.61%3.345
28.89%0.58
Diluted earnings per share
11.94%1.125
-21.96%0.4448
-43.13%0.455
-35.44%2.15
-137.93%-0.22
21.08%1.005
21.28%0.57
-0.62%0.8
34.55%3.33
28.89%0.58
Dividend per share
0
6.22%1.881
0
6.86%1.7708
0
0
6.86%1.7708
0
4.18%1.6572
0
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 11.49%14.16B6.53%11.38B2.35%11.12B2.32%46.44B6.50%12.2B-3.35%12.7B-0.56%10.68B8.06%10.86B15.86%45.39B10.00%11.46B
Operating revenue 12.32%13.44B7.83%10.75B2.37%10.46B0.17%43.07B1.81%10.92B-4.15%11.96B-1.49%9.97B5.66%10.22B13.87%43B7.31%10.73B
Cost of revenue 6.35%4.09B4.35%3.41B11.69%3.44B3.95%14.24B8.41%4.05B0.26%3.84B0.55%3.27B6.91%3.08B11.75%13.7B7.45%3.73B
Gross profit 13.72%10.07B7.50%7.97B-1.35%7.68B1.62%32.21B5.58%8.15B-4.84%8.86B-1.04%7.41B8.52%7.78B17.73%31.69B11.27%7.72B
Operating expense 10.76%5.98B8.32%5.69B9.77%5.45B10.11%21.82B15.76%6.2B15.92%5.4B0.69%5.25B8.32%4.96B11.48%19.81B4.61%5.36B
Selling and administrative expenses 3.96%2.68B3.11%2.66B-0.08%2.61B1.91%10.69B1.24%2.93B-2.46%2.58B0.04%2.58B9.58%2.61B9.81%10.49B4.97%2.9B
Research and development costs 11.37%1.85B4.54%1.7B9.98%1.72B0.33%6.73B2.69%1.87B-4.21%1.66B-1.69%1.63B4.97%1.56B17.81%6.71B15.02%1.82B
Depreciation amortization depletion -14.77%479M-8.61%499M14.93%562M5.80%2.17B25.82%575M-18.08%562M18.44%546M8.91%489M29.94%2.05B8.81%457M
-Depreciation and amortization -14.77%479M-8.61%499M14.93%562M5.80%2.17B25.82%575M-18.08%562M18.44%546M8.91%489M29.94%2.05B8.81%457M
Other operating expenses 62.37%971M65.87%831M84.87%562M295.73%2.22B356.11%821M247.29%598M-4.21%501M14.72%304M-40.59%562M-49.44%180M
Operating profit 18.35%4.09B5.50%2.28B-20.91%2.23B-12.53%10.39B-17.45%1.95B-25.65%3.46B-5.01%2.16B8.88%2.82B29.89%11.88B29.98%2.37B
Net non-operating interest income expense 24.57%-132M-175.68%-204M-1,357.14%-102M-121.88%-639M-363.41%-380M-243.14%-175M3.90%-74M91.03%-7M22.16%-288M34.40%-82M
Non-operating interest income -6.99%133M-4.17%92M-6.21%151M215.61%546M34.48%117M175.00%143M300.00%96M1,510.00%161M5,666.67%173M422.22%87M
Non-operating interest expense -16.67%265M-8.78%135M50.60%253M42.95%659M-117.16%-29M208.74%318M46.53%148M90.91%168M18.51%461M48.25%169M
Total other finance cost --------------526M------------------------
Other net income (expense) -86.07%-454M-123.86%-685M-118.44%-782M-122.03%-2.6B-194.69%-1.7B87.31%-244M63.74%-306M-84.54%-358M-19.61%-1.17B737.01%1.79B
Gain on sale of security -------------253.70%-83M----------------28.57%54M----
Special income (charges) -86.07%-454M-95.65%-765M-160.37%-703M-105.47%-2.52B-192.86%-1.61B87.31%-244M53.67%-391M-53.41%-270M-19.98%-1.23B630.89%1.74B
-Less：Restructuring and merger&acquisition 0.76%264M112.89%677M182.35%720M20.93%1.58B373.42%748M-23.39%262M-50.16%318M49.12%255M58.86%1.31B-48.53%158M
-Less:Impairment of capital assets 4,400.00%180M---354M-213.33%-17M297.36%896M141.23%877M-99.75%4M--0200.00%15M-336.46%-454M-14,280.00%-2.13B
-Less:Other special charges 145.45%10M---------89.73%38M-105.58%-13M-340.00%-22M--------7,300.00%370M--233M
Other non- operating income (expenses) --------10.23%-79M-----------------388.89%-88M--------
Income before tax 15.38%3.5B-21.89%1.39B-45.15%1.35B-31.37%7.15B-102.97%-121M13.58%3.04B31.51%1.78B5.91%2.46B33.65%10.42B187.99%4.08B
Income tax 30.91%737M10.33%299M-64.27%164M-20.14%1.6B-66.04%309M-6.32%563M66.26%271M38.25%459M28.75%2.01B232.12%910M
Earnings from equity interest net of tax 20.00%78M137.50%24M-408.33%-37M-269.12%-115M-4,366.67%-128M828.57%65M-328.57%-64M-60.00%12M74.36%68M-83.33%3M
Net income 12.06%2.84B-22.81%1.12B-42.96%1.15B-35.93%5.44B-117.61%-558M22.08%2.54B18.61%1.45B-0.40%2.01B35.12%8.48B173.34%3.17B
Net income continuous Operations 12.06%2.84B-22.81%1.12B-42.96%1.15B-35.93%5.44B-117.61%-558M22.08%2.54B18.61%1.45B-0.40%2.01B35.12%8.48B173.34%3.17B
Minority interest income 123.08%29M-66.67%4M-7.14%13M-68.14%36M-105.26%-3M333.33%13M-73.33%12M75.00%14M101.79%113M470.00%57M
Net income attributable to the parent company 11.49%2.82B-22.44%1.11B-43.21%1.13B-35.49%5.4B-117.84%-555M21.63%2.53B22.13%1.44B-0.70%2B34.52%8.37B170.76%3.11B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.49%2.82B-22.44%1.11B-43.21%1.13B-35.49%5.4B-117.84%-555M21.63%2.53B22.13%1.44B-0.70%2B34.52%8.37B170.76%3.11B
Basic earnings per share 11.94%1.125-21.93%0.445-43.13%0.455-35.58%2.155-137.93%-0.2221.08%1.00521.28%0.57-0.62%0.834.61%3.34528.89%0.58
Diluted earnings per share 11.94%1.125-21.96%0.4448-43.13%0.455-35.44%2.15-137.93%-0.2221.08%1.00521.28%0.57-0.62%0.834.55%3.3328.89%0.58
Dividend per share 06.22%1.88106.86%1.7708006.86%1.770804.18%1.65720
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.94%